Pamidronate Medac (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamidronate Medac, is a bisphosphonate presented as a unknown/unknown for intravenous use. It inhibits bone resorption and is employed in the management of skeletal complications associated with malignancy and certain metabolic bone diseases. GNH USA supplies Pamidronate Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Pamidronate Medac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Pamidronate Medac is a bisphosphonate that acts on abnormal  the       ​   ​  ​  ​  ​  ​  ​        ​  ​     …

- Hyper‑         ... ...  ...  ... ... … … … … … … … … -  …  ....  .... .... .... .... .... .... .... .... .... ...

    ....  ....